The dual GIP/GLP-1 action produces stronger and earlier appetite suppression for most patients
CMAJ (2020)
A study on glutathione supplementation in NAFLD patients reported significant reductions in ALT levels after 4 months of treatment, with early improvements detectable at the 4-8 week mark (Honda et al., 2017)
Evidence status Phase 2 trial
Cameron Foster of The Boulos Company and Melody Allred of CARR represented the tenant, Gameday Mens Health, while Joe Atwood of The Dunham Group represented the landlord, Rock Coast Space1, LLC
"The combination of GHRH analogs such as CJC-1295 and GHRPs like Ipamorelin synergistically enhances GH secretion, promoting recovery, muscle regeneration, and sleep quality key components of athletic performance and rehabilitation." Walker et al., Growth Hormone & IGF Research Clinical Evidence CJC-1295 has been shown to elevate GH and IGF-1 for sustained periods, leading to improvements in lean body mass, tissue repair, and overall recovery capacity